Free Trial

Brainstorm Cell Therapeutics (BCLI) News Today

Brainstorm Cell Therapeutics logo
$1.14 -0.03 (-2.56%)
Closing price 03:55 PM Eastern
Extended Trading
$1.15 +0.01 (+1.23%)
As of 04:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BCLI Latest News

Brainstorm Cell Therapeutics Inc. (BCLI) - Yahoo Finance
Q4 2024 Brainstorm Cell Therapeutics Inc Earnings Call
A Preview Of Brainstorm Cell's Earnings
BrainStorm granted compliance extension from Nasdaq
BrainStorm Issues 2024 Letter to Shareholders
BrainStorm regains compliance with Nasdaq
Get Brainstorm Cell Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BCLI and its competitors with MarketBeat's FREE daily newsletter.

BCLI Media Mentions By Week

BCLI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BCLI
News Sentiment

0.00

0.54

Average
Medical
News Sentiment

BCLI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BCLI Articles
This Week

1

1

BCLI Articles
Average Week

Get Brainstorm Cell Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BCLI and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:BCLI) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners